Ralexar Therapeutics, Inc. — Form D
Ralexar Therapeutics, Inc. of Encinitas, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-04. The offering totals $6.0M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-01-04
- Form: D
- Accession: 0001596494-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $1.9M
- Remaining: $4.1M
- Investors: 11
- Date of first sale: 2018-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-329633
Issuer
- Name: Ralexar Therapeutics, Inc.
- CIK: 0001596494
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 662 Encinitas Blvd., Encinitas, CA, 92024
- Phone: 484-318-2988
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Douglas Gessl | Executive Officer | Wayne, PA |
| Somu Subramaniam | Director | South San Francisco, CA |
| Neal Walker | Director | Malvern, PA |
| Somasundaram Subramaniam | Director | San Diego, CA |
| Raju Mohan | Executive Officer | San Diego, CA |
| Stephen Tullman | Director | Malvern, PA |
| Stephen Tullman | Executive Officer | Malvern, PA |
| JASON HONG | Director | STAMFORD, CT |
| Kamil Ali-Jackson | Executive Officer | Wayne, PA |
| David Pfeiffer | Director | Wayne, PA |
| David Pfeiffer | Executive Officer | Wayne, PA |
Other filings by this issuer (4)
More